Skip to main content
2025 SECO Annual Congress Main banner
Back

SECO 2025

AOA CE HOURS

COPE-GL

CEE-TQ

OD FL

OD IL

OD SC

OD TX

AOA-PARA

60 - Hot Topic Breakfast - The Future of Glaucoma Management: Perspectives from Leading Experts

Thursday, February 27, 2025
8:00 AM – 10:45 AM EST
Location: Georgia World Congress Center, 411/412
CE Hours: 2
The treatment, management, theories, myths, and debate are ever evolving when it comes to glaucoma. This course will tackle a variety of hot topics in glaucoma with the panel having a robust discussion on how or if these topics should be incorporated in the care of your glaucoma patients.

Learning Objectives:

Upon conclusion of this activity, attendees will be able to:
  • Understand the considerations of first line therapy for glaucoma in the year 2025
  • Understand the various MIGS procedures that have made surgery NOT become the last resort for the treatment of glaucoma patients
  • Understand the use of Anterior Segment OCT in the use of analyzing the angle
  • Understand the quality-of-life issues that face many of our glaucoma patients
  • Understand the latest data around OCT-A and its use in glaucoma management
  • Understand the data surrounding LPI’s in the use of prophylactic care of anatomically narrow angles
Disclosure(s):
Justin Schweitzer, OD: AbbVie/Allergan: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Alcon: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Aldeyra Therapeutics: Consulting Fees (); Bausch + Lomb: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Bruder: Advisory Committee/Board Member (), Consulting Fees (); Dompe: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Eyenovia Bio: Consulting Fees (); Glaukos: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Heru: Consulting Fees (); Iveric Bio: Consulting Fees (); LKC: Advisory Committee/Board Member (), Consulting Fees (); Mediprint: Advisory Committee/Board Member (), Consulting Fees (); Ocuphire: Advisory Committee/Board Member (), Consulting Fees (); Reichert: Consulting Fees (); Santen: Consulting Fees (); Science Based Health: Advisory Committee/Board Member (), Consulting Fees (); Sight Sciences: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Sun Pharma: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Tarsus Pharma: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Thea Pharma: Consulting Fees (); Viatris: Consulting Fees (); Visus Therapeutics: Advisory Committee/Board Member (), Consulting Fees (); ZEISS: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) ()
Bobby Saenz, OD, MS, FAAO, II: Oyster Point: Consulting Fees ()
Jill C. Autry, OD, RPh: AbbVie/Allergan: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); RVL: Advisory Committee/Board Member (); Tarsus: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) ()
Jessica Steen, OD: AbbVie/Allergan: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Alcon: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Astellas: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Bausch + Lomb: Consulting Fees (); Carl Zeiss Meditec: Consulting Fees (); Clearside Biomedical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); iCare: Advisory Committee/Board Member (); Ocuphire: Advisory Committee/Board Member (); Ocuterra: Advisory Committee/Board Member (); Peripherex: Advisory Committee/Board Member (); Radius XR: Advisory Committee/Board Member (); Santen: Advisory Committee/Board Member (); Viatris: Consulting Fees ()